BioNTech Sued in Germany for Injuries from the Comirnaty COVID mRNA Shot
Pharmaceutical company BioNTech SE of Mainz, Germany is facing a lawsuit filed by a German health care worker who was injured by the company’s Comirnaty COVID-19 messenger RNA (mRNA) shot, which it developed in collaboration with Pfizer, Inc. of the United States. The plaintiff said she suffered pain in her upper body, extreme swelling, fatigue […]
Most COVID Vaccine Injury Claims Not Compensated
The U.S. government has received thousands of COVID-19 vaccine injury claims. As of May 31, 2023, 8,208 people had filed requests for compensation with the Department of Health and Human Services’ (HHS) Countermeasures Injury Compensation Program (CICP) after developing serious health problems following COVID shots.1 The CICP has only adjudicated 749 of the 8,208 injury […]
FDA Revokes EUA for Johnson & Johnson/Janssen’s COVID Vaccine
On June 1, 2023, the U.S. Food and Drug Administration (FDA) withdrew the Emergency Use Authorization (EUA) Johnson & Johnson/Janssen’s adenovirus vectored Ad26.COV2.S (also known as JNJ-78436735) COVID-19 vaccine that had been granted to the companies on Feb. 27, 2021. The FDA noted that Janssen requested the voluntary withdrawal of the EUA in a letter […]
More U.S. Parents Reject HPV Vaccine Over Safety Concerns
A growing number of parents in the U.S. are choosing not to vaccinate their adolescent children for human papillomavirus (HPV), according to a new study published in the June 2023 edition of the journal Pediatrics.1 The study identified HPV vaccine uptake trends in an effort to develop strategies to combat increasing vaccine hesitancy. The researchers […]
3D Printed Vaccine Skin Patches Being Developed
In an attempt to increase consumer demand for COVID-19 shots, researchers have designed a vaccine printer that can print COVID messenger RNA (mRNA) skin patches in bulk, producing as many as 100 patches in 48 hours. The microneedle patches, which contain mRNA molecules in lipid nanoparticles, could pave the way for unlimited distribution of the […]
RSV Vaccine Approved by FDA for Adults 60 and Older
The U.S. Food and Drug Administration (FDA) has approved a license for the world’s first respiratory syncytial virus (RSV) vaccine to be given to people 60 years of age and older. Pharmaceutical and biotechnology company GSK (formerly GlaxoSmithKline) has already begun manufacturing doses of the vaccine, which will be sold as early as this fall […]
